Enveric Biosciences closes ~$5M public offering of stock and warrants

Enveric Biosciences, Inc.

Gross proceeds ~$5M, net ~$4.3M from sale of 1.67M shares/pre-funded, Series A & B warrants at $3.00/unit.
Series A warrants (5-yr, $3.00 strike) and Series B warrants (18-mo, $3.00 strike) are exercisable immediately.
Proceeds earmarked for EB-003 development, working capital, and general corporate purposes.
H.C. Wainwright acted as placement agent, receiving 7% cash fee plus warrants to purchase 116,666 shares at $3.75.
Offering closed on February 3, 2025, with pre-funded warrants exercisable at $0.0001 per share.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.